Cervical cytology
Conditions
Interventions
Group A Postpartum women
Group B other women
Sponsors
Dr ADARAMOYE Emmanuel Dare
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: This study will involve a sample of seemingly healthy women who are attending the usual 6th week postnatal clinic, as well as non-pregnant women who are attending the gynaecology clinic and family planning clinic at the study centre.
Exclusion criteria
Exclusion criteria: 1. Past history of abnormal cervical smear: The individual has a previous medical record indicating an abnormal result from a cervical smear test. 2. Past history of cervical cancer: The historical background of cervical cancer. 3. History of cervical surgery or hysterectomy. 4. Abnormal vaginal discharge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure to be assessed will be: 1.The prevalence of women exhibiting abnormal Pap smear results after their six-week postnatal checkup. 2. The prevalence of women with abnormal Pap smears in non-pregnant women attending gynecology clinics and family planning clinics. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome of the study will be: 1. The level of acceptance (acceptability) of Pap Smear at the 6th Week postnatal visit. 2. The distribution or categorization of participants with abnormal Pap smear results into those diagnosed with no squamous epithelial lesion, atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical glandular cells (AGC), squamous cell cancer, and adenocarcinoma. | — |
Countries
Nigeria
Contacts
Public ContactEmmanuel Adewara
Consultant
Outcome results
None listed